CLINICAL
STUDIES
Learn about some clinical studies that have been involved by Science Valley:
TREATMENT
MICHELLE
Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy
ClinicalTrials.gov Identifier:
NCT04662684
KNOW MORE
TREATMENT
STRUCK TRIAL
Survival Trial Using CytoKines
ClinicalTrials.gov Identifier:
NCT04724629
KNOW MORE
TREATMENT
BTK
Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19
ClinicalTrials.gov Identifier:
NCT04528667
KNOW MORE
TREATMENT
COMET-ICE
VIR-7831 for the Early Treatment of COVID-19 in Outpatients
ClinicalTrials.gov Identifier:
NCT04545060
KNOW MORE
VACCINE
CLINERGY
A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19)
ClinicalTrials.gov Identifier:
NCT04510207
KNOW MORE
VACCINE
CLOVER
Clostridium Difficile Vaccine Efficacy Trial
ClinicalTrials.gov Identifier:
NCT03090191
KNOW MORE
STRATEGIC PORTFOLIO
VALERIA
Efficacy and safety of rivaroxaban 10 mg once daily versus enoxaparin 40 mg once daily for prophylaxis of venous thromboembolism in gynecological cancer surgery.
ClinicalTrials.gov Identifier:
In Progress
STRATEGIC PORTFOLIO
AGRIPPA
Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients
ClinicalTrials.gov Identifier:
NCT04229264